pharma news today obesity glp-1 A diabetes drug. Then a weight-loss drug. Then a global blockbuster. Here's how GLP-1s went from helping manage blood sugar to becoming one of medicine's biggest stories. [GLP-1, Ozempic, Wegovy, Mounjaro, diabetes GLP-1 Agonists Weight Loss Drugs

Although the tests are sometimes unreliable because glutathione is known to fluctuate widely, doctors can still use plasma and blood testing as a baseline

Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer

It cannot replace healthy habits or deliver results for those who still need to lose weight

Morgan JE

Patients experiencing sleep disturbances while taking tirzepatide can implement several strategies to improve sleep quality without discontinuing beneficial therapy

Beyond diabetes and obesity, research is now underway to explore the potential of GLP-1 agonists for other conditions like kidney disease, heart failure, Alzheimers, Parkinsons, sleep apnea and drug addiction, she said